CVS HEALTH CORPORATION (CVS) FY2026 Q2 P&L / Income Statement

CVS HEALTH CORPORATION (CVS) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Product and service (5 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenues

106,096,000,000 US dollars

Total operating costs

101,393,000,000 US dollars

Operating income

4,703,000,000 US dollars

Other income (expense), net (calculated)

negative 726,000,000 US dollars

Income before income tax provision

3,977,000,000 US dollars

Income tax provision

982,000,000 US dollars

Net income

2,995,000,000 US dollars

Products

66,219,000,000 US dollars

Services

4,119,000,000 US dollars

Premiums: Government

28,494,000,000 US dollars

Premiums: Commercial

6,625,000,000 US dollars

Net investment income

641,000,000 US dollars

Cost of products sold

58,862,000,000 US dollars

Health care costs

31,485,000,000 US dollars

Operating expenses

11,046,000,000 US dollars

Revenue before reconciliation (calculated)

106,098,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.

Components above reported revenue (calculated)

negative 2,000,000 US dollars. The disclosed components add up to more than reported revenue; this is the difference, calculated, not a reported item.

Chart connections

• Revenue minus operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
• Of which attributable to CVS HEALTH CORPORATION: $2.98 B; to noncontrolling interests: $16.00 M.